In the media

Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Learn more
How a new HIV medicine reduced carbon emissions

How a new HIV medicine reduced carbon emissions

Learn more
Latin America is catching up on HPV vaccination and screening

Latin America is catching up on HPV vaccination and screening

Learn more
Wider use of material-saving HIV drug cutting CO2 emissions: Report

Wider use of material-saving HIV drug cutting CO2 emissions: Report

Learn more
World’s leading HIV drug reduces carbon emissions by 26 million tons In comparison to predecessor

World’s leading HIV drug reduces carbon emissions by 26 million tons In comparison to predecessor

Learn more
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

Learn more
Game-changing HIV shot can’t get to high-risk groups fast enough

Game-changing HIV shot can’t get to high-risk groups fast enough

Learn more
HIV trial shows injectable prevents 100% infection in women and girls

HIV trial shows injectable prevents 100% infection in women and girls

Learn more
1 2 3 4